Exploration
Accueil
Racine
Exploration
Accueil
Racine

Serveur d'exploration Tocilizumab

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Le cluster Jun Fukae - Kazuhide Tanimura

Terms

9Jun Fukae
10Kazuhide Tanimura
8Tamotsu Kamishima
8Masato Shimizu
9Megumi Matsuhashi
21Tatsuya Atsumi

Associations

Freq.WeightAssociation
90.949Jun Fukae - Kazuhide Tanimura
80.943Jun Fukae - Tamotsu Kamishima
80.943Jun Fukae - Masato Shimizu
80.943Masato Shimizu - Megumi Matsuhashi
80.894Kazuhide Tanimura - Tamotsu Kamishima
80.894Kazuhide Tanimura - Masato Shimizu
80.889Jun Fukae - Megumi Matsuhashi
70.875Masato Shimizu - Tamotsu Kamishima
80.843Kazuhide Tanimura - Megumi Matsuhashi
70.825Megumi Matsuhashi - Tamotsu Kamishima
60.463Masato Shimizu - Tatsuya Atsumi
60.436Megumi Matsuhashi - Tatsuya Atsumi
60.436Jun Fukae - Tatsuya Atsumi
60.414Kazuhide Tanimura - Tatsuya Atsumi
50.386Tamotsu Kamishima - Tatsuya Atsumi
Documents par ordre de pertinence
002731 (2013) Jun Fukae [Japon] ; Masato Isobe ; Akemi Kitano ; Mihoko Henmi ; Fumihiko Sakamoto ; Akihiro Narita ; Takeya Ito ; Akio Mitsuzaki ; Masato Shimizu ; Kazuhide Tanimura ; Megumi Matsuhashi ; Tamotsu Kamishima ; Tatsuya Atsumi ; Takao KoikePositive synovial vascularity in patients with low disease activity indicates smouldering inflammation leading to joint damage in rheumatoid arthritis: time-integrated joint inflammation estimated by synovial vascularity in each finger joint.
003906 (2011) Jun Fukae [Japon] ; Masato Isobe ; Akemi Kitano ; Mihoko Henmi ; Fumihiko Sakamoto ; Akihiro Narita ; Takeya Ito ; Akio Mitsuzaki ; Masato Shimizu ; Kazuhide Tanimura ; Megumi Matsuhashi ; Tamotsu Kamishima ; Tatsuya Atsumi ; Takao KoikeRadiographic prognosis of finger joint damage predicted by early alteration in synovial vascularity in patients with rheumatoid arthritis: Potential utility of power doppler sonography in clinical practice.
003B80 (2011) Jun Fukae [Japon] ; Masato Isobe [Japon] ; Akemi Kitano [Japon] ; Mihoko Henmi [Japon] ; Fumihiko Sakamoto [Japon] ; Akihiro Narita [Japon] ; Takeya Ito [Japon] ; Akio Mitsuzaki [Japon] ; Masato Shimizu [Japon] ; Kazuhide Tanimura [Japon] ; Megumi Matsuhashi [Japon] ; Tamotsu Kamishima [Japon] ; Tatsuya Atsumi [Japon] ; Takao Koike [Japon]Radiographic Prognosis of Finger Joint Damage Predicted by Early Alteration in Synovial Vascularity in Patients With Rheumatoid Arthritis: Potential Utility of Power Doppler Sonography in Clinical Practice
003B84 (2011) Tamotsu Kamishima [Japon] ; Kazuhide Tanimura [Japon] ; Masato Shimizu [Japon] ; Megumi Matsuhashi [Japon] ; Jun Fukae [Japon] ; Yujiro Kon [Royaume-Uni] ; Hiromi Hagiwara [Japon] ; Akihiro Narita [Japon] ; Yuko Aoki [Japon] ; Naoki Kosaka [Japon] ; Tatsuya Atsumi [Japon] ; Hiroki Shirato [Japon] ; Satoshi Terae [Japon]Monitoring anti-interleukin 6 receptor antibody treatment for rheumatoid arthritis by quantitative magnetic resonance imaging of the hand and power Doppler ultrasonography of the finger
003D68 (2010) Tamotsu Kamishima [Japon] ; Kazuhide Tanimura [Japon] ; Masato Shimizu [Japon] ; Megumi Matsuhashi [Japon] ; Jun Fukae [Japon] ; Yujiro Kon [Royaume-Uni] ; Hiromi Hagiwara [Japon] ; Akihiro Narita [Japon] ; Yuko Aoki [Japon] ; Naoki Kosaka [Japon] ; Tatsuya Atsumi [Japon] ; Hiroki Shirato [Japon] ; Satoshi Terae [Japon]Monitoring anti-interleukin 6 receptor antibody treatment for rheumatoid arthritis by quantitative magnetic resonance imaging of the hand and power Doppler ultrasonography of the finger
000B83 (2019) Toshiyuki Watanabe [Japon] ; Jun Fukae [Japon] ; Shinji Fukaya [Japon] ; Norifumi Sawamukai [Japon] ; Masato Isobe [Japon] ; Megumi Matsuhashi [Japon] ; Masato Shimizu [Japon] ; Kazumasa Akikawa [Japon] ; Kazuhide Tanimura [Japon] ; Tatsuya Atsumi [Japon] ; Takao Koike [Japon]Incidence and risk factors for reactivation from resolved hepatitis B virus in rheumatoid arthritis patients treated with biological disease-modifying antirheumatic drugs.
003B75 (2011) Tamotsu Kamishima [Japon] ; Kazuhide Tanimura [Japon] ; Yuko Aoki [Japon] ; Naoki Kosaka [Japon] ; Masato Shimizu [Japon] ; Megumi Matsuhashi [Japon] ; Jun Fukae [Japon] ; Yujiro Kon [Royaume-Uni] ; Satoshi Terae [Japon] ; Hiroki Shirato [Japon]Simplified approach to MR image quantification of the rheumatoid wrist: a pilot study
003D46 (2010) Tamotsu Kamishima [Japon] ; Kazuhide Tanimura [Japon] ; Yuko Aoki [Japon] ; Naoki Kosaka [Japon] ; Masato Shimizu [Japon] ; Megumi Matsuhashi [Japon] ; Jun Fukae [Japon] ; Yujiro Kon [Royaume-Uni] ; Satoshi Terae [Japon] ; Hiroki Shirato [Japon]Simplified approach to MR image quantification of the rheumatoid wrist: a pilot study
000D84 (2019) Kazuki Kato ; Nobutoshi Yasojima ; Kenichi Tamura ; Shota Ichikawa [Japon] ; Kenneth Sutherland ; Masaru Kato ; Jun Fukae ; Kazuhide Tanimura ; Yuki Tanaka ; Taichi Okino ; Yutong Lu ; Tamotsu KamishimaDetection of Fine Radiographic Progression in Finger Joint Space Narrowing Beyond Human Eyes: Phantom Experiment and Clinical Study with Rheumatoid Arthritis Patients
000298 (2020) Yoshikazu Nakaoka ; Mitsuaki Isobe ; Yoshiya Tanaka ; Tomonori Ishii ; Seido Ooka ; Hiroaki Niiro [Japon] ; Naoto Tamura ; Shogo Banno ; Hajime Yoshifuji [Japon] ; Yasushi Sakata ; Atsushi Kawakami ; Tatsuya Atsumi ; Shunsuke Furuta ; Hitoshi Kohsaka ; Katsuya Suzuki ; Ryoki Hara ; Yasuhiro Maejima ; Hiroshi Tsukamoto ; Yoshinari Takasaki ; Katsuhisa Yamashita ; Norihiro Okada ; Shinji Yamakido ; Syuji Takei ; Shumpei Yokota [Japon] ; Norihiro Nishimoto [Japon]Long-term efficacy and safety of tocilizumab in refractory Takayasu arteritis: final results of the randomized controlled phase 3 TAKT study.
000581 (2020) Atsushi Noguchi [Japon] ; Shinsuke Yasuda [Japon] ; Ryo Hisada [Japon] ; Masaru Kato [Japon] ; Kenji Oku [Japon] ; Toshiyuki Bohgaki [Japon] ; Miho Suzuki [Japon] ; Yoshihiro Matsumoto [Japon] ; Tatsuya Atsumi [Japon]Anti-cyclic citrullinated peptide antibody titers decrease in rheumatoid arthritis patients treated with tocilizumab: A pilot study.
000892 (2019) Kenji Oku [Japon] ; Tatsuya Atsumi [Japon]Rheumatology practice in Japan: challenges and opportunities.
000965 (2019) Masaru Kato [Japon] ; Yuko Kaneko [Japon] ; Yoshiya Tanaka [Japon] ; Masayuki Inoo [Japon] ; Hitomi Kobayashi-Haraoka [Japon] ; Koichi Amano [Japon] ; Masayuki Miyata [Japon] ; Yohko Murakawa [Japon] ; Hidekata Yasuoka [Japon] ; Shintaro Hirata [Japon] ; Hayato Nagasawa [Japon] ; Eiichi Tanaka [Japon] ; Nobuyuki Miyasaka [Japon] ; Hisashi Yamanaka [Japon] ; Kazuhiko Yamamoto [Japon] ; Isao Yokota [Japon] ; Tatsuya Atsumi [Japon] ; Tsutomu Takeuchi [Japon]Predictive value of serum amyloid a levels for requirement of concomitant methotrexate in tocilizumab initiation: A post hoc analysis of the SURPRISE study.
001185 (2018) Shun Tanimura [Japon] ; Masaru Kato [Japon] ; Nobuya Abe [Japon] ; Hiroshi Ohira [Japon] ; Ichizo Tsujino [Japon] ; Tatsuya Atsumi [Japon]Successful treatment of tocilizumab-resistant large vessel pulmonary arteritis with infliximab.
001213 (2018) Tatsuya Atsumi [Japon] ; Keishi Fujio [Japon] ; Kunihiro Yamaoka [Japon] ; Minako Tomobe [Japon] ; Kazuyuki Kuroyanagi [Japon] ; Hideto Kameda [Japon]Safety and effectiveness of subcutaneous tocilizumab in patients with rheumatoid arthritis in a real-world clinical setting.
001247 (2018) Tatsuya Atsumi [Japon] ; Yoshiaki Ando [Japon] ; Shinichi Matsuda [Japon] ; Shiho Tomizawa [Japon] ; Riwa Tanaka [Japon] ; Nobuhiro Takagi [Japon] ; Ayako Nakasone [Japon]Prodromal signs and symptoms of serious infections with tocilizumab treatment for rheumatoid arthritis: Text mining of the Japanese postmarketing adverse event-reporting database.
001833 (2017) Naoki Ishiguro [Japon] ; Tatsuya Atsumi [Japon] ; Masayoshi Harigai [Japon] ; Tsuneyo Mimori [Japon] ; Norihiro Nishimoto [Japon] ; Takayuki Sumida [Japon] ; Tsutomu Takeuchi [Japon] ; Yoshiya Tanaka [Japon] ; Ayako Nakasone [Japon] ; Nobuhiro Takagi ; Hisashi Yamanaka [Japon]Effectiveness and safety of tocilizumab in achieving clinical and functional remission, and sustaining efficacy in biologics-naive patients with rheumatoid arthritis: The FIRST Bio study.
001974 (2016) Naonobu Sugiyama [Japon] ; Yutaka Kawahito [Japon] ; Takao Fujii [Japon] ; Tatsuya Atsumi [Japon] ; Tatsunori Murata [Japon] ; Yosuke Morishima [Japon] ; Yuri Fukuma [Japon]Treatment Patterns, Direct Cost of Biologics, and Direct Medical Costs for Rheumatoid Arthritis Patients: A Real-world Analysis of Nationwide Japanese Claims Data.
001A79 (2016) Takeru Tsujimoto [Japon] ; Masahiko Takahata [Japon] ; Terufumi Kokabu [Japon] ; Megumi Matsuhashi [Japon] ; Norimasa Iwasaki [Japon]Pyogenic spondylodiscitis following anti-interleukin-6 therapy in a patient with rheumatoid arthritis (implication of hematogenous infection risk in degenerative intervertebral discs): A case report and review of the literature.
001C25 (2016) Yuko Kaneko [Japon] ; Tatsuya Atsumi [Japon] ; Yoshiya Tanaka [Japon] ; Masayuki Inoo [Japon] ; Hitomi Kobayashi-Haraoka [Japon] ; Koichi Amano [Japon] ; Masayuki Miyata [Japon] ; Yohko Murakawa [Japon] ; Hidekata Yasuoka [Japon] ; Shintaro Hirata [Japon] ; Hayato Nagasawa [Japon] ; Eiichi Tanaka [Japon] ; Nobuyuki Miyasaka [Japon] ; Hisashi Yamanaka [Japon] ; Kazuhiko Yamamoto [Japon] ; Tsutomu Takeuchi [Japon]Comparison of adding tocilizumab to methotrexate with switching to tocilizumab in patients with rheumatoid arthritis with inadequate response to methotrexate: 52-week results from a prospective, randomised, controlled study (SURPRISE study).
001E94 (2015) Atsushi Ogata [Japon] ; Tatsuya Atsumi [Japon] ; Takaaki Fukuda [Japon] ; Yasuhiko Hirabayashi [Japon] ; Masaaki Inaba [Japon] ; Naoki Ishiguro [Japon] ; Motokazu Kai [Japon] ; Daisuke Kawabata [Japon] ; Daihei Kida [Japon] ; Hitoshi Kohsaka [Japon] ; Ryutaro Matsumura [Japon] ; Seiji Minota [Japon] ; Masaya Mukai [Japon] ; Takayuki Sumida [Japon] ; Kiyoshi Takasugi [Japon] ; Shigenori Tamaki [Japon] ; Tsutomu Takeuchi [Japon] ; Atsuhisa Ueda [Japon] ; Kazuhiko Yamamoto [Japon] ; Hisashi Yamanaka [Japon] ; Hajime Yoshifuji [Japon] ; Akira Nomura [Japon]Sustainable Efficacy of Switching From Intravenous to Subcutaneous Tocilizumab Monotherapy in Patients With Rheumatoid Arthritis.
002380 (2014) Atsushi Ogata [Japon] ; Kazuhide Tanimura ; Toyohiko Sugimoto ; Hiroshi Inoue ; Yukitomo Urata ; Tsukasa Matsubara ; Masakazu Kondo ; Yukitaka Ueki ; Mitsuhiro Iwahashi ; Shigeto Tohma ; Shuji Ohta ; Yukihiko Saeki ; Toshio TanakaPhase III study of the efficacy and safety of subcutaneous versus intravenous tocilizumab monotherapy in patients with rheumatoid arthritis.
002827 (2013) Akito Takamura [Japon] ; Shintaro Hirata ; Hayato Nagasawa ; Hideto Kameda ; Yohei Seto ; Tatsuya Atsumi ; Makoto Dohi ; Takao Koike ; Nobuyuki Miyasaka ; Masayoshi HarigaiA retrospective study of serum KL-6 levels during treatment with biological disease-modifying antirheumatic drugs in rheumatoid arthritis patients: a report from the Ad Hoc Committee for Safety of Biological DMARDs of the Japan College of Rheumatology.
003572 (2012) Ryoko Sakai [Japon] ; Michi Tanaka [Japon] ; Toshihiro Nanki [Japon] ; Kaori Watanabe [Japon] ; Hayato Yamazaki [Japon] ; Ryuji Koike [Japon] ; Hayato Nagasawa [Japon] ; Koichi Amano [Japon] ; Kazuyoshi Saito [Japon] ; Yoshiya Tanaka [Japon] ; Satoshi Ito [Japon] ; Takayuki Sumida [Japon] ; Atsushi Ihata [Japon] ; Yoshiaki Ishigatsubo [Japon] ; Tatsuya Atsumi [Japon] ; Takao Koike [Japon] ; Atsuo Nakajima [Japon] ; Naoto Tamura [Japon] ; Takao Fujii [Japon] ; Hiroaki Dobashi [Japon] ; Shigeto Tohma [Japon] ; Takahiko Sugihara [Japon] ; Yukitaka Ueki [Japon] ; Akira Hashiramoto [Japon] ; Atsushi Kawakami [Japon] ; Noboru Hagino [Japon] ; Nobuyuki Miyasaka [Japon] ; Masayoshi Harigai [Japon]Drug retention rates and relevant risk factors for drug discontinuation due to adverse events in rheumatoid arthritis patients receiving anticytokine therapy with different target molecules
003F14 (2009) Ryuji Koike [Japon] ; Masayoshi Harigai ; Tatsuya Atsumi ; Koichi Amano ; Shinichi Kawai ; Kazuyoshi Saito ; Tomoyuki Saito ; Masahiro Yamamura ; Tsukasa Matsubara ; Nobuyuki MiyasakaJapan College of Rheumatology 2009 guidelines for the use of tocilizumab, a humanized anti-interleukin-6 receptor monoclonal antibody, in rheumatoid arthritis.
004333 (????) Hiroyuki Nakamura [Japon] ; Tatsuro Sugai [Japon] ; Masaru Kato [Japon] ; Kanako C. Hatanaka [Japon] ; Tatsuya Atsumi [Japon]Subcutaneous panniculitis-like T-cell lymphoma with haemophagocytic syndrome during tocilizumab therapy for juvenile idiopathic arthritis.
Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021